Treatment outcomes in patients older than age 60 with acute myeloid leukemia (AML) in the nonclinical trial setting

被引：0
|
作者：
Duffy, Steven
Bains, Puneet
Pavlovitz, Brian
Vajpayee, Neerja
Newman, Nancy
Gajra, Ajeet
机构：
[1] SUNY Upstate Med Univ, Syracuse, NY 13210 USA
[2] Lions Gate Hosp, N Vancouver, BC, Canada
[3] Rochester Gen Hlth Syst, Dept Pathol, Rochester, NY USA
[4] SUNY Upstate Med Univ, Dept Pathol, Syracuse, NY 13210 USA
[5] SUNY Upstate Med Univ, Cazenovia, NY USA
[6] Upstate Med Univ, Syracuse, NY USA
[7] VAMC, Syracuse, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6572
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Reduced intensity (RI) allogeneic hematopoietic cell transplantation (HCT) improves outcomes for older (≥ 60 yrs) patients (pts) with acute myeloid leukemia (AML).
    O'Donnell, Margaret R.
    Stein, Anthony S.
    Nakamura, Ryotaro
    Slovak, Marilyn L.
    Tsai, Nicole
    Palmer, Joycelynne
    Rodriguez, Roberto
    Spielberger, Ricardo
    Smith, Eileen P.
    Snyder, David S.
    Parker, Pablo M.
    Popplewell, Leslie
    Pullarkat, Vinod
    Karames, Chatchada
    Kogut, Neil
    Somlo, George
    Forman, Stephen J.
    BLOOD, 2007, 110 (11) : 330A - 330A
  • [42] Acute Myeloid Leukemia (AML) Hospitalizations: Racial Disparity in Outcomes of Patients with Comorbidities
    Alam, Sara Taveras
    Dongarwar, Deepa
    Lopez, Elyse
    Yellapragada, Sarvari Venkata
    Rivero, Gustavo
    Miller-Chism, Courtney Nicole
    Mims, Martha P.
    Huang, Quillan
    Salihu, Hamisu
    BLOOD, 2021, 138
  • [43] Outcomes of patients with newly diagnosed acute myeloid leukemia (AML) and hyperleukocytosis.
    Haddad, Fadi
    Sasaki, Koji
    Abuasab, Tareq
    Venugopal, Sangeetha
    Rivera, Daniel
    Bazinet, Alexandre
    Babakhanlou, Rodrick
    Kim, Kunhwa
    Senapati, Jayastu
    Ong, Faustine
    Desikan, Sai Prasad
    Short, Nicholas James
    Pemmaraju, Naveen
    Borthakur, Gautam
    Dinardo, Courtney Denton
    Daver, Naval Guastad
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Kadia, Tapan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E19029 - E19029
  • [44] Impact of Hyperglycemia and Age on Outcomes in Patients With Acute Myeloid Leukemia
    Storey, Susan
    Von Ah, Diane
    ONCOLOGY NURSING FORUM, 2016, 43 (05) : 595 - 601
  • [45] Racial Disparities in Inpatient Outcomes for Patients Admitted with Acute Myeloid Leukemia (AML)
    Khan, Fayaz
    Rahima, Kenan
    Singeltary, Brian Patrick
    Zamani, Taraneh
    Durhman, Madelyn
    Jose, Thulasee
    BLOOD, 2024, 144 : 2433 - 2434
  • [46] Association between glycemic control, age, and outcomes among intensively treated patients with acute myeloid leukemia (AML).
    Kuhlman, Patrick
    Isom, Scott
    Pardee, Timothy S.
    Burns, Cynthia
    Tawfik, Bernard
    Lamar, Zanetta S.
    Powell, Bayard L.
    Klepin, Heidi D.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [47] TREATMENT-ASSOCIATED SURVIVAL RATES IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML): A SYSTEMATIC LITERATURE REVIEW
    Bell, J.
    Galaznik, A.
    Huelin, R.
    Stokes, M.
    Faller, D.
    Fram, R.
    HAEMATOLOGICA, 2017, 102 : 388 - 388
  • [48] Treatment intensity in older patients with acute myeloid leukemia.
    Büchner, T
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 1999, 32 (02): : 291 - 291
  • [49] Novel Strategies in the Treatment of Older Patients with Acute Myeloid Leukemia
    Kadia, Tapan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S51 - S53
  • [50] Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the study alliance leukemia
    Mueller-Tidow, C.
    Tschanter, P.
    Roellig, C.
    Thiede, C.
    Koschmieder, A.
    Stelljes, M.
    Koschmieder, S.
    Dugas, M.
    Gerss, J.
    Butterfass-Bahloul, T.
    Wagner, R.
    Eveslage, M.
    Thiem, U.
    Krause, S. W.
    Kaiser, U.
    Kunzmann, V.
    Steffen, B.
    Noppeney, R.
    Herr, W.
    Baldus, C. D.
    Schmitz, N.
    Goetze, K.
    Reichle, A.
    Kaufmann, M.
    Neubauer, A.
    Schaefer-Eckart, K.
    Haenel, M.
    Peceny, R.
    Frickhofen, N.
    Kiehl, M.
    Giagounidis, A.
    Goerner, M.
    Repp, R.
    Link, H.
    Kiani, A.
    Naumann, R.
    Bruemmendorf, Th
    Serve, H.
    Ehninger, G.
    Berdel, W. E.
    Krug, U.
    LEUKEMIA, 2016, 30 (03) : 555 - 561
12345